What is the clinical evidence from this study?

Study design: Review. Population: Alzheimer's disease. Intervention: APOE ε3 and ε4 alleles vs. APOE ε2 allele. Primary outcome: Alzheimer's disease.

What question did this study set out to answer?

This research aims to clarify the role of different APOE alleles in the development and risk of Alzheimer's disease.

July 5, 2026Open Access

Understanding apolipoprotein E as a predominant cause of Alzheimer's disease

View Full Paper

Ask AI

Bookmark

Key result

APOE ε3 and ε4 drive most Alzheimer's disease, suggesting APOE modulation benefits nearly all cases.

Population

Populations with Alzheimer's disease, including those of European ancestry and other ethnic groups.

Design

Review

Authors

DWDylan M. WilliamsUniversity of Southern California NMNaaheed MukadamUniversity College London Hospitals NHS Foundation Trust NDNeil M DaviesUniversity of London

Discussion

Member takes

Implication

Epidemiological evidence suggests that APOE is a predominant cause of Alzheimer's disease across various etiologies, highlighting it as a broad therapeutic target.

Key Points

This research aims to clarify the role of different APOE alleles in the development and risk of Alzheimer's disease.
Analyzed the impact of APOE ε2, ε3, and ε4 alleles on Alzheimer's disease risk in populations of European ancestry and other ethnic groups.
Reviewed epidemiological evidence linking APOE function to late-onset and sporadic early-onset Alzheimer's disease.
The majority of late-onset Alzheimer's cases are associated with the APOE ε3 and ε4 alleles.
Most sporadic early-onset Alzheimer's cases are linked to the contributions of APOE ε3 and ε4 alleles.
Epidemiological evidence suggests that APOE is central to the causes of various forms of Alzheimer's disease.

Structured PICO

Population

Populations with Alzheimer's disease (late-onset, early-onset, genetic mutations, and trisomy 21), including those of European ancestry and other ethnic groups.

Epidemiological evidence suggests that APOE is a predominant cause of Alzheimer's disease across various etiologies, highlighting it as a broad therapeutic target.

Cite This Study

Williams et al. (2026) conducted a review in Alzheimer's disease. APOE ε3 and ε4 alleles vs. APOE ε2 allele was evaluated on Alzheimer's disease. The APOE ε3 and ε4 alleles are predominant causes of Alzheimer's disease across various etiologies, suggesting that modulating APOE function could benefit almost all prospective cases.

synapsesocial.com/papers/6a49f68df5d1d45b28800dfd https://doi.org/10.5281/zenodo.21168619

View Full Paper

Ask AI

Bookmark

Implication

Epidemiological evidence suggests that APOE is a predominant cause of Alzheimer's disease across various etiologies, highlighting it as a broad therapeutic target.

Understanding apolipoprotein E as a predominant cause of Alzheimer's disease

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Understanding apolipoprotein E as a predominant cause of Alzheimer's disease

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Also Consider

Also Consider